
Canature Health plans to establish a wholly-owned subsidiary in the cell industry to create a second growth curve

According to the Zhitong Finance APP, Canature Health announced that the company plans to establish a wholly-owned subsidiary with its own funds in regions such as Hainan Province or Hunan Province to engage in the cell industry business and industry mergers and acquisitions, with a registered capital of 100 million yuan for the wholly-owned subsidiary. The establishment of this wholly-owned subsidiary will strengthen Canature Health's layout in the cell industry, enter the cell industry business and industry mergers and acquisitions, thereby creating the cell industry as the company's second growth curve
According to the Zhitong Finance APP, Canature Health (300272.SZ) announced that the company plans to establish a wholly-owned subsidiary in Hainan Province or Hunan Province with its own funds to engage in the cell industry business and industry mergers and acquisitions. The registered capital of the wholly-owned subsidiary will be 100 million yuan. The establishment of this wholly-owned subsidiary will strengthen Canature Health's layout in the cell industry, enter the cell industry business and industry mergers and acquisitions, thereby creating the cell industry as the company's second growth curve

